https://www.onclive.com/view/salvage-checkpoint-inhibitors-reduce-peri-asct-progression-in-r-r-hodgkin-lymphoma
0
0
2/18/23 at 12:05pm
Organization
OncLive
Author
Ashling Wahner
41 words
0
Comments
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.
You are the first to view
Create an account
or login to join the discussion